Barclays upgraded Sirius XM Holdings Inc. (NASDAQ:SIRI) to “overweight” from “equal weight” this morning, though the shares have shed 12.2% so far this month to trade at $3.17. Meanwhile, in the options pits, speculators have bought to open SIRI calls over puts at a near-annual-high pace during the past two weeks, as the equity’s 10-day International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) call/put volume ratio of 26.33 ranks 2 percentage points from a 12-month peak. Considering Sirius XM Holdings Inc.’s current price, it is likely that option players are turning to long calls, due to the limited profit potential of long puts. Sirius XM Holdings Inc. (NASDAQ:SIRI) stock opened today at $3.22 and is currently trading at $3.25. The stock showed a positive weekly performance of -6.49%.
Facebook Inc. (NASDAQ:FB) has taken a dive into the virtual reality space, announcing a $2 billion deal to acquire Oculus VR Inc., a virtual reality headset maker founded in 2012 Facebook Inc (NASDAQ:FB) stock opened at $64.04, in current trading session and currently is at $64.32, by loosing -1.13%.The 52 week range of $22.67-$72.59.Company’s market capitalization is $163.23 billion.
Insmed Incorporated (Nasdaq: INSM) reported results from the Company’s phase 2 clinical trial of ARIKAYCE, or liposomal amikacin for inhalation, for the treatment of patients with treatment resistant nontuberculous mycobacterial (NTM) lung infections. The randomized, double-blind, placebo-controlled phase 2 clinical trial compared ARIKAYCE (590 mg delivered once daily), added to standard of care treatment, versus standard of care treatment plus placebo, in 90 adult patients with treatment resistant NTM lung disease. Eligibility for the study required patients to have been on the American Thoracic Society/Infectious Disease Society of America (ATS/IDSA) guideline therapy for at least six months prior to screening and to continue to have persistently positive mycobacterial cultures.Insmed Incorporated (NASDAQ:INSM) stock is currently trading at $16.40 .The EPS of the stock is -1.59. Company’s market capitalization is $636.66 million.
Yongye International, Inc (NASDAQ:YONG) announced that, at the special meeting of stockholders of the Company held on March 5, 2014, the proposal to approve the previously announced agreement and plan of merger, dated as of September 23, 2013, among the Company, Full Alliance International Limited, Yongye International Limited and Yongye International Merger Sub Limited), did not receive approval from at least a majority of the issued and outstanding shares of common stock of the Company, other than Shares owned by Holdco, Parent and Merger Sub, including shares to be contributed to Parent by Holdco, Mr. Zishen Wu, Prosper Sino Development Limited and MSPEA Agriculture Holding Limited, immediately prior to the effective time of the Merger pursuant to a contribution agreement, dated as of September 23, 2013, among Parent, Holdco, Mr. Zishen Wu, Prosper Sino Development Limited and MSPEA Agriculture Holding Limited, and Shares held by the Company or any subsidiary of the Company. Yongye International, Inc (NASDAQ:YONG) stock opened the session at $6.75, and now is at $6.79. The 52 week range of the YONG stock remained $4.83-$6.86 and the day range was $6.72-$6.86.